Seoulin Competitors

Stocks . Korea . 
Stock . Seoulin Bioscience CoLtd
038070 Stock  KRW 7,100  30.00  0.42%   
Seoulin Bioscience CoLtd competes with Samsung Electronics, Samsung Electronics, SK Hynix, SK Holdings, and POSCO Holdings; as well as few others. Analyzing Seoulin Bioscience competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Seoulin Bioscience to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Seoulin Bioscience Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Seoulin Bioscience competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
7,0947,1007,106
Details
Intrinsic
Valuation
LowRealHigh
6,1246,1307,810
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Seoulin Bioscience. Your research has to be compared to or analyzed against Seoulin Bioscience's peers to derive any actionable benefits. When done correctly, Seoulin Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Seoulin Bioscience CoLtd.

Seoulin Bioscience Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Seoulin Bioscience and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Seoulin and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Seoulin Bioscience CoLtd does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
005385
+ 0.97
005387
005385
+ 0.95
005380
005935
+ 0.92
005930
005380
+ 0.9
005387
005490
+ 0.81
034730
005490
+ 0.8
005935
  
High negative correlations   
000270
- 0.52
005490
000270
- 0.32
005935
000270
- 0.14
005930
000270
- 0.11
005387
000270
- 0.11
034730
000270
- 0.08
005385

Risk-Adjusted Indicators

There is a big difference between Seoulin Stock performing well and Seoulin Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Seoulin Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Seoulin Bioscience Competitive Analysis

The better you understand Seoulin Bioscience competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Seoulin Bioscience's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Seoulin Bioscience's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
038070 005930 005935 000660 034730 005490 005387 005380 005385 000270
 0.42 
 7,100 
Seoulin
 1.10 
 53,700 
Samsung
 0.45 
 43,850 
Samsung
 2.14 
 214,500 
000660
 0.27 
 146,800 
034730
 0.76 
 260,000 
POSCO
 2.20 
 160,000 
Hyundai
 3.42 
 211,500 
Hyundai
 2.15 
 154,500 
Hyundai
 1.84 
 101,500 
Kia
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Weak
Very Weak
Very Weak
Modest
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Low
Low
Low
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Hold
Buy
Cautious Hold
Buy
Hold
Hold
Hold
Strong Hold
Hold
Current Ratio
3.06
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Asset
136.57 B
426.62 T
426.62 T
96.39 T
165.38 T
91.47 T
233.95 T
233.95 T
233.95 T
66.85 T
Profit Margin
0.22
0.18
0.18
0.19
0.0266
0.0611
0.046
0.046
0.046
0.0573
EBITDA
9.94 B
88.03 T
88.03 T
24.33 T
15.85 T
15.76 T
12.82 T
12.82 T
12.82 T
8.78 T
Operating Margin
0.0986
0.14
0.14
0.26
0.0706
0.0883
0.0592
0.0592
0.0592
0.0718
Current Valuation
165.44 B
289.78 T
289.78 T
72.86 T
66.09 T
30.19 T
126.62 T
126.14 T
126.62 T
13.85 T
Price To Book
N/A
1.23
1.1
0.82
0.45
0.39
0.25
0.5
0.25
0.65
Retained Earnings
26.92 B
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
33.75 B
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
0.76
0.95
0.95
0.93
0.82
1.06
1.04
1.04
1.04
1.22
Number Of Employees
91
10
10
10
4.09 K
10
64.05 K
64.05 K
64.05 K
34.18 K
Shares Outstanding
7.3 M
5.97 B
822.89 M
687.65 M
55.41 M
75.81 M
34.77 M
202.26 M
21.93 M
400.93 M
Cash Flow From Operations
8.92 B
65.11 T
65.11 T
19.8 T
6.13 T
6.26 T
(1.18 T)
(1.18 T)
(1.18 T)
7.36 T
Annual Yield
0.0076
0.023
0.0258
0.0293
0.0402
0.0267
0.0803
0.0403
0.0782
0.0488
Total Debt
15.22 B
509.73 B
509.73 B
14.74 T
42.62 T
12.93 T
74.13 T
74.13 T
74.13 T
4.93 T
Return On Equity
10.81
0.17
0.17
0.15
0.12
0.1
0.0796
0.0796
0.0796
0.13
Z Score
3.0
N/A
N/A
2.4
N/A
0.6
N/A
N/A
N/A
4.0
Return On Asset
0.0554
0.062
0.062
0.0838
0.0317
0.0491
0.02
0.02
0.02
0.0515
Book Value Per Share
7430.02
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Liabilities
10.11 B
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
136.57 B
426.62 T
426.62 T
96.39 T
165.38 T
91.47 T
233.95 T
233.95 T
233.95 T
66.85 T
Debt To Equity
0.012
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Target Price
N/A
75711.0
65400.0
116956.0
320000.0
381421.0
N/A
224275.0
N/A
96808.0
Last Dividend Paid
N/A
1444.0
1448.0
2740.0
8000.0
8000.0
7100.0
7000.0
7050.0
3500.0
Shares Owned By Institutions
1.55
27.58
35.3
38.42
18.56
32.09
33.23
22.55
22.6
26.54
Market Capitalization
85.27 B
424.25 T
424.67 T
64.23 T
10.97 T
23.28 T
42.38 T
40.36 T
41.27 T
29.47 T
Price To Earning
42.3
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earnings To Growth
N/A
4.0
3.6
25.81
N/A
0.9
N/A
N/A
N/A
N/A
Price To Sales
1.05
1.29
1.29
1.1
0.0877
0.24
0.28
0.28
0.28
0.32
Net Income
15.77 B
39.24 T
39.24 T
9.6 T
1.97 T
6.62 T
4.94 T
4.94 T
4.94 T
4.76 T
Earnings Per Share
N/A
1039.75
873.86
187.08
3119.0
8435.16
N/A
9669.19
N/A
4660.93
Shares Owned By Insiders
31.19
19.25
0.07
25.6
25.98
1.93
N/A
30.24
N/A
37.47
Revenue
80.72 B
279.6 T
279.6 T
43 T
98.33 T
76.33 T
117.61 T
117.61 T
117.61 T
69.86 T
Working Capital
23.64 B
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
14.97 B
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
16.52 B
112.19 T
112.19 T
18.95 T
11.04 T
11.86 T
21.93 T
21.93 T
21.93 T
12.87 T
Day Typical Price
7130.0
53666.67
43933.33
213667.0
146467.0
260667.0
161267.0
213500.0
155600.0
101633.0
Accumulation Distribution
1154.17
311080.0
9541.31
195987.0
2113.38
2333.69
2381.09
25714.53
1463.17
23127.05
Market Facilitation Index
0.0043
0.0
7.0E-4
0.0017
0.0414
0.0261
0.0452
0.0087
0.053
0.0028
Daily Balance Of Power
(0.16)
(0.67)
(0.36)
0.5294
0.1111
(0.50)
(0.86)
(1.07)
(0.97)
(0.73)
Period Momentum Indicator
(30.00)
(600.00)
(200.00)
4500.0
400.0
(2,000)
(3,600)
(7,500)
(3,400)
(1,900)
Rate Of Daily Change
1.0
0.99
1.0
1.02
1.0
0.99
0.98
0.97
0.98
0.98
Day Median Price
7145.0
53650.0
43975.0
213250.0
146300.0
261000.0
161900.0
214500.0
156150.0
101700.0
Price Action Indicator
(60.00)
(250.00)
(225.00)
3500.0
700.0
(2,000)
(3,700)
(6,750)
(3,350)
(1,150)
Coefficient Of Variation
3225.05
(1,517)
(1,430)
1434.73
(4,244)
(578.81)
(1,674)
(1,275)
(1,119)
3348.56
Mean Deviation
2.93
1.66
1.6
2.47
1.64
1.82
1.31
1.58
1.14
1.64
Jensen Alpha
0.1568
(0.16)
(0.16)
0.2101
(0.06)
(0.47)
(0.11)
(0.18)
(0.14)
0.0536
Total Risk Alpha
0.1796
(0.15)
(0.15)
0.224
(0.05)
(0.46)
(0.10)
(0.17)
(0.14)
0.0631
Sortino Ratio
0.0387
N/A
N/A
0.0725
N/A
N/A
N/A
N/A
N/A
0.0295
Downside Variance
17.21
N/A
N/A
8.73
N/A
N/A
N/A
N/A
N/A
3.8
Standard Deviation
5.39
2.23
2.14
3.17
2.02
2.68
1.7
2.15
1.49
2.15
Kurtosis
14.35
1.41
1.62
0.2288
(0.50)
3.42
(0.04)
1.29
0.5976
0.4297
Potential Upside
7.47
3.52
2.9
5.95
3.55
4.17
2.58
4.73
2.51
4.03
Treynor Ratio
(1.58)
4.0
(1.98)
(1.06)
(0.78)
2.42
0.4383
0.468
1.75
(0.34)
Maximum Drawdown
44.21
10.64
10.84
14.36
7.23
17.75
7.99
8.76
6.48
9.75
Variance
29.07
4.97
4.58
10.04
4.1
7.19
2.89
4.63
2.23
4.61
Market Risk Adjusted Performance
(1.57)
4.01
(1.97)
(1.05)
(0.77)
2.43
0.4483
0.478
1.76
(0.33)
Risk Adjusted Performance
0.0344
(0.05)
(0.05)
0.0656
(0.01)
(0.14)
(0.04)
(0.06)
(0.07)
0.0311
Skewness
2.38
0.7863
0.6933
0.4137
0.4228
(0.10)
0.0925
0.6476
0.5668
0.5701
Semi Deviation
3.9
N/A
N/A
2.69
N/A
N/A
N/A
N/A
N/A
1.87
Information Ratio
0.0298
(0.07)
(0.07)
0.0676
(0.03)
(0.18)
(0.06)
(0.08)
(0.09)
0.0268
Value At Risk
(7.08)
(3.51)
(3.25)
(4.52)
(2.86)
(4.52)
(2.94)
(3.43)
(2.17)
(2.95)
Expected Short fall
(3.62)
N/A
N/A
(2.76)
N/A
N/A
N/A
N/A
N/A
(1.81)
Downside Deviation
4.15
N/A
N/A
2.96
N/A
N/A
N/A
N/A
N/A
1.95
Semi Variance
15.22
N/A
N/A
7.26
N/A
N/A
N/A
N/A
N/A
3.51

Seoulin Bioscience Competition Performance Charts

Five steps to successful analysis of Seoulin Bioscience Competition

Seoulin Bioscience's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Seoulin Bioscience CoLtd in relation to its competition. Seoulin Bioscience's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Seoulin Bioscience in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Seoulin Bioscience's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Seoulin Bioscience CoLtd, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Seoulin Bioscience position

In addition to having Seoulin Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Blockchain Thematic Idea Now

Blockchain
Blockchain Theme
Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. The Blockchain theme has 31 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Blockchain Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Seoulin Stock

Seoulin Bioscience financial ratios help investors to determine whether Seoulin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seoulin with respect to the benefits of owning Seoulin Bioscience security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY